Enhanced prostaglandin E2 secretion in sputum from asthmatic patients after zafirlukast therapy

Journal of the Formosan Medical Association

Volumn 100, Issue 4, 2001, Pages 240-243

  Tsai, Jaw Ji ^a   Su, Yung Chang ^a   Chan, Shu Chen ^a   Ho, Chia Kuan ^b   Feng, Ta Cheng ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Asthma; Eosinophil cationic protein; Leukotriene E4; Prostaglandin E2

Indexed keywords

AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; LEUKOTRIENE; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PROSTAGLANDIN E2; ZAFIRLUKAST; ANTIASTHMATIC AGENT; EOSINOPHIL GRANULE PROTEIN; PLASMA PROTEIN; RIBONUCLEASE; TOLUENESULFONIC ACID DERIVATIVE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BLOOD SAMPLING; BLOOD VESSEL PERMEABILITY; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EOSINOPHIL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MEDIATOR; MODULATION; MUCUS SECRETION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PROSTAGLANDIN RELEASE; SPUTUM; DRUG EFFECT; METABOLISM; MIDDLE AGED; SECRETION;

ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; BLOOD PROTEINS; DINOPROSTONE; EOSINOPHIL GRANULE PROTEINS; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE E4; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; RIBONUCLEASES; SPUTUM; TOSYL COMPOUNDS;

EID: 0035317348     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dahlen SE, Hedqvist P, Hammarsterom S, et al: Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484-6.
2. O'Byrne PM: Leukotrienes in the pathogenesis of asthma. Chest 1997;111:27S-34S.
3. Roquet A, Dahlen B, Kumlin M, et al: Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997;155:1856-63.
4. Calhoun WJ, Lavins B, Minkwitz MC, et al: Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge. Am J Respir Crit Care Med 1998;157:138-9.
5. Adkins JC, Brogden RN: Zafirlukast: a review of its pharmacology and therapeutic potential in the management of asthma. Drugs 1998;55:121-44.
6. Rosenthal R, Lavins BJ, Hanby LA: Effect of treatment with zafirlukast (Accolate) on bronchial hyperresponsiveness in patients with mild to moderate asthma. J Allergy Clin Immunol 1996;97:250.
7. Churchill L, Chilton FH, Resau JH, et al: Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis 1989; 140:449-59.
8. Liu MC, Hubbard WC, Pround D, et al: Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular mediators, and permeability changes. Am Rev Respir Dis 1991;144:51-8.
9. Ayers GH, Altman LC, Gleich GJ, et al: Eosinophil and eosinophil-mediated pneumocyte injury. J Allergy Clin Immunol 1985;76:595-604.
10. Shaw RJ, Walsh GM, Cromwell O, et al: Activated human eosinophil generated SRS-A leukotrienes following IgG-dependent stimulation. Nature 1985;316: 105-12.
11. Standards for diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
12. Drazen JM, Israel E, O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999:340;197-206.
13. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with folin phenol reagent. J Biol Chem 1951;193: 265-75.
14. 2 on allergen-induced asthma. Am Rev Respir Dis 1993;148:87-90.
15. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994;149: 1138-41.
16. 4 in normal and asthmatic subjects. Am Rev Respir Dis 1987;135:333-7.
17. Venge P: Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 1993; 23(suppl 2):3-7.
18. Kappa A, Czech W, Krutmann J, et al: Eosinophil cationic protein in sera of patients with atopic dermatitis. J Am Acad Dermatol 1991;24:555-8.
19. Lairinen LA, Laitinen A, Haahtela T, et al: Leukotriene E(4) and granulocytic infiltration into asthmalic airways. Lancet 1993;341:989-90.
20. Henderson WR Jr: The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-97.